Doctor Practice Financing – Click Here for 100 percent financing for doctors starting up a practice or acquiring one!
Call: 904-551-6090
As you decide to start this important personal process, you will be required to create a detailed business plan that will include all the required elements for the medical practice. This formulated business plan will be of use to us so that we can be able to assess your general operation. You will be pleased to know that as lenders we are dedicated to undertake a fair assessment process of your plan so that we can effectively provide for the required finances that will be sufficient to handle all the initial company processes. With the cash-flow project that will be reflected by your business plan, you will be set to obtain a reasonable amount to money for your medical practice.
Read The Interesting Snippets Below For Exciting Health-Care News!
* 15.7 months benefit compared with Herceptin and chemotherapy
(Adds comment from Allergan in paragraph 8; refiled to correct typographical error in headline)
MADRID (Reuters) – Using vaccines to fight cancer is a field littered with failures but experts believe it is possible the approach could get a new lease of life if such shots are combined with a new class of drugs called checkpoint inhibitors.
MADRID (Reuters) – Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive.
Sept 27 (Reuters) – The U.S. National Institutes of Health plans to admit to one of its special observation wards an American physician exposed to the Ebola virus while volunteering in Sierra Leone, it said on Saturday.
MADRID, Sept 28 (Reuters) – Continuing to give AstraZeneca’s drug Iressa plus chemotherapy to lung cancer patents whose disease has worsened after previously taking the medicine on its own does not provide any benefit.
Medical Practice Loans!
No down payment medical, dental and healthcare provider practice financing here! + More News: UPDATE 1-Shareholder T. Rowe Price urges Allergan to hold off on deals + MORE 09/28/2014
No comments:
Post a Comment